Cardiovascular risk factors and behavior lifestyles of young women: Implications from findings of the bogalusa heart study

American Journal of the Medical Sciences

Volumn 314, Issue 6, 1997, Pages 385-395

  O'Neil, Carol E ^a   Nicklas, Theresa A ^a   Myers, Leann ^a   Johnson, Carolyn C ^a   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

Author keywords

Cardiovascular risk factors; Nutrition; Women's health

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CORONARY RISK; FAMILY HISTORY; FAT INTAKE; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; ONSET AGE; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SITTING; UNITED STATES;

EID: 0031441297     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199712000-00005     Document Type: Article

References (113)

1. 1997 Heart and Stroke Statistical Update. Data from Vital Statistics of the United States, National Center for Health Statistics and the American Heart Association, 1996.
2. Harris-Hooker S, Sanford GL. Lipids, lipoproteins and coronary heart disease in minority populations. Atherosclerosis. 1994;108(suppl):S83-104.
3. American Heart Association. Women and Heart Disease: Summary of Proceedings. Washington DC: October 26-27, 1989.
4. Tofler G, Stone PH, Muller JE, et al. Effects of gender and race on prognosis after myocardial infarction: Adverse prognosis for women, particularly black women. J Am Coll Cardiol. 1987;9:473-82.
5. Cooper RS, Simmons B, Castaner A, et al. Survival rates and prehospital delay during myocardial infarction among black persons. Am J Cardiol. 1986;57:208-11.
6. Kuhn FE, Rackley CE. Coronary artery disease in women. Risk factors, evaluation, treatment, and prevention. Arch Intern Med. 1993;153:2626-36.
7. Kris-Etherton PM, Krummel D. Role of nutrition in the prevention and treatment of coronary heart disease in women. J Am Diet Assoc. 1993;93:987-93.
8. Brezinka V, Padmos I. Coronary heart disease risk factors in women. Eur Heart J. 1994;15:1571-84.
9. LaRosa JC. Dyslipoproteinemia in women and the elderly. Med Clin North Am. 1994;78:163-80.
10. Barrett-Connor E. Heart disease in women. Fertil Steril. 1994;62(suppl 2):127S-32S.
11. Judelson DR. Coronary heart disease in women: Risk factors and prevention. JAMA. 1994;49:186-91, 197.
12. Oettgen P, Douglas PS. Coronary artery disease in women: Diagnosis and prevention. Adv Intern Med. 1994;39:467-84.
13. Brunner D, Weisbort J, Meshulam N, et al. Relation of serum and total cholesterol and high density lipoprotein cholesterol percentage to the incidence of definite coronary events: Twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol. 1987;59:1271-6.
14. Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem. 1988;44:60-70.
15. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M, et al. Special Report: Cardiovascular Disease in Women. American Heart Association Medical/Scientific Statement. Circulation. 1993;88(4 pt 1):1999-2009.
16. Wilson PWF, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality: The Framingham Heart Study. Arteriosclerosis. 1988;8(6):737-41.
17. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383-90.
18. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the lipid research clinics program follow-Up study. Circulation. 1987;75:1102-9.
19. Kwiterovich PO, Coresh J, Smith HH, et al. Comparisons of the plasma levels of apolipoproteins B and A-1 and other risk factors in men and women with premature coronary artery disease. Am J Cardiol. 1992;69:1015-21.
20. Lapidus L, Bengtsson C, Lindquist O, et al. Triglycerides: Main lipid risk for cardiovascular disease in women. Acta Med Scand. 1985;217:481-9.
21. Castelli WP. The triglyceride issue: A view from Framingham. Am Heart J. 1986;112:432-7.
22. Berenson GS, Srinivasan SR, Cresanta, et al. Dynamic changes in serum lipoproteins in children during adolescence and sexual maturation. Am J Epidemiol. 1981;113:157-70.
23. Srinivasan SR, Dahlen GH, Jarpa, et al. Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children: Bogalusa Heart Study. Circulation. 1991;84:160-7.
24. Lindquist O. Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: Results from a prospective population study of women in Goteborg, Sweden. Prev Med. 1982;11:162-72.
25. Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors from coronary heart disease. N Engl J Med. 1989;321:641-6.
26. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 1993;98:83-90.
27. Freedman DS, Srinivasan SR, Cresanta JL, et al. Cardiovascular risk disease risk factors from birth to seven years of age: Bogalusa Heart Study. IV. Serum lipids and lipoproteins. Pediatrics. 1987;80(suppl):789-96.
28. Srinivasan SR, Frerichs RR, Webber, et al. Serum lipoprotein profile in children from a biracial community: The Bogalusa Heart Study. Circulation. 1976;54:309-18.
29. Nicklas TA, Webber LS, Johnson CC, Srinivasan SR, Berenson GS. Foundations for health promotion with youth: A review of observations from the Bogalusa Heart Study. J Health Educ 1995;26(2):S-18-26.
30. Donahue RP, Jacobs DR, Sidney S, et al. Distribution of lipoproteins and apolipoproteins in young adults. The CARDIA Study. Arteriosclerosis. 1989;9:656-64.
31. Manolio TA, Furberg CD, Shemanski L, et al. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group. Circulation. 1993;88:2163-71.
32. Brown SA, Hutchinson R, Morrisett J, et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis Thromb. 1993;13:1139-58.
33. Kannel WN. Metabolic risk factors for coronary heart disease in women: Perspectives from the Framingham Study. Am Heart J. 1987;114:413-9.
34. Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-β estradiol. Metabolism. 1992;41:1110-4.
35. Psaty BM, Heckbert SR, Atkins, et al. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med. 1993;153:1421-7.
36. Webber LS, Srinivasan SR, Wattigney W, et el. Tracking of serum lipids and lipoproteins from childhood to adulthood - The Bogalusa Heart Study. Am J Epidemiol. 1991;133:884-99.
37. Voors AW, Foster TA, Frerichs RR, Webber LS, Berenson GS. Studies of blood pressure in children ages 5-14, in a total biracial community - The Bogalusa Heart Study. Circulation. 1976;54:319-27.
38. Lauer RM, Clarke WR, Beaglehole R. Level, trend and variability of blood pressure during childhood: The Muscatine Study. Circulation. 1984;69:242-9.
39. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med. 1993;153:154-83.
40. Fiebach N, Hebert P, Stampfer M, et al. A prospective study of high blood pressure and cardiovascular disorders in women. Am J Epidemiol. 1989;130:646-54.
41. Bush TL. The epidemiology of cardiovascular disease in postmenopausal women. Ann N Y Acad Sci. 1990;592:263-71.
42. Wattigney WA, Webber LS, Srinivasan SR, Berenson GS. The emergence of clinically abnormal levels of cardiovascular disease risk factor variables among young adults: The Bogalusa Heart Study. Prev Med. 1995;24:617-26.
43. Keller C. Coronary artery disease in blacks. J Cardiovasc Nurs. 1990;4:4-12.
44. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population based study. Am J Epidemiol. 1983;118:489-96.
45. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care. 1979;2:120-6.
46. Heyden S, Heiss G, Bartel AG, Hames CG. Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chronic Dis. 1980;33:265-73.
47. Barrett-Connor E, Cohn BA, Wingard DL, et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA. 1991;265:627-31.
48. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141-7.
49. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893-8.
50. Barrett-Connor E, Witzum JL, Holdbrook M. A community study of high density lipoproteins in adult noninsulin-dependent diabetes. Am J Epidemiol. 1983;117:186-92.
51. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. populations ages 20-74 yr. Diabetes. 1987;36:523-34.
52. Svec F, Nastasi K, Hilton C, Bao W, Srinivasan SR, Berenson GS. Black-white contrasts in insulin levels during pubertal development. Diabetes. 1992;41:313-7.
53. Berenson GS, Voors AW, Webber LS, et al. Racial difference of parameters associated with blood pressure levels in children: The Bogalusa Heart Study. Metabolism. 1979; 28:1218-28.
54. Voors AW, Harsha DW, Webber LS, et al. Clustering of anthropometric parameters, glucose tolerance, and serum lipids in children with high and low beta- and pre-beta-lipoproteins: Bogalusa Heart Study. Arteriosclerosis. 1982;2:346-55.
55. Freedman DS, Srinivasan SR, Harsha D, et al. Relation of body fat patterning to lipid and lipoprotein in children and adolescents: The Bogalusa Heart Study. Am J Clin Nutr. 1989;50:930-9.
56. Berenson GS, Radhakrishnamurthy B, Bao W, et al. Does adult-onset diabetes mellitus begin in childhood? The Bogalusa Heart Study. Am J Med Sci. 1995;310(suppl 1):S77-82.
57. Mann GV. The influence of obesity on health (Part II). N Engl J Med. 1974;291:226-32.
58. Dyer AR, Stamler J, Berkson DM, et al. Relationship of relative weight and body mass index to 14-year mortality in the Chicago Peoples Gas Company Study. J Chronic Dis. 1975;28:109-23.
59. Van Itallie TB. Obesity: Adverse effects of health and longevity. Am J Clin Nutr. 1979;32:2723-33.
60. Andres R. Effect of obesity on total mortality. Int J Obes. 1980;4:381-6.
61. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-77.
62. Manson JE, Colditz GA, Stampfer MJ, et al. Study of obesity and risk of coronary disease in women. N Engl J Med. 1990;322:882-9.
63. Barrett-Connor EL. Obesity, atherosclerosis and coronary artery disease. Ann Intern Med. 1985;103:1010-9.
64. Himes JH and Dietz WH. Guidelines for overweight in adolescent preventive services: Recommendations from an expert committee. Am J Clin Nutr. 1994;59:307-16.
65. Webber LS, Wattigney, Srinivasan S, et al. Obesity studies in Bogalusa. Am J Med Sci. 1995;310(suppl 1):S53-61.
66. Smoak CG, Burke GL, Webber LS, et al. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1987;125:364-72.
67. Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in older women. JAMA. 1993;269:483-7.
68. Soler JT, Folsom AR, Kushi LH, et al. Association of body fat distribution with plasma lipids, lipoproteins, apolipoproteins AI and B in postmenopausal women. J Clin Epidemiol. 1988;41:1075-81.
69. Despres J-P, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497-511.
70. Hansen EF, Andersen LT, Von Eyben FE. Cigarette smoking and age at first onset of myocardial infarction and influence of gender and extent of smoking. Am J Cardiol. 1993;71:1439-42.
71. Kannel WB. New perspectives on cardiovascular risk factors. Am Heart J. 1987;114:213-9.
72. Webber LS, Hunter SMacD, Johnson CC, Srinivasan SR, Berenson GS. Smoking, alcohol, and oral contraceptives. Ann N Y Acad Sci. 1991;623:135-54.
73. Johnson A. Sex differentials in coronary heart disease: The explanatory role of primary risk factors. J Health Soc Behav. 1977;18:46-54.
74. Pierce J, Fiore M, Novotny V, et al. Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA. 1989;261:61-5.
75. Eaker ED, Packard B, Thom TJ. Epidemiology and risk factors for coronary heart disease in women. Cardiovasc Clin. 1989;19:129-45.
76. Webber LS, Hunter S MacD, Baugh JG, et al. The interaction of cigarette smoking, oral contraceptive use and cardiovascular risk factor variables in children: The Bogalusa Heart Study. Am J Public Health. 1982;72:266-74.
77. Freedman DS, Srinivasan SR, Shear CL, et al. Cigarette smoking initiation and longitudinal changes in serum lipids and lipoproteins in early adulthood: The Bogalusa Heart Study. Am J Epidemiol. 1986;124:207-19.
78. Willett W, Hennekens CH, Castelli W, et al. Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL Cholesterol in women. Am Heart J. 1983;105:417-21.
79. Mant D, Villard Mackintosh L, Vessey MP, et al. Myocardial infarction and angina pectoris in young women. J Epidemiol Community Health. 1987;41:215-9.
80. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987; 317:1303-9.
81. Wilson PW, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med. 1985;313:1038-43.
82. Slone D, Shapiro S, Kaufman DW, et al. Risk of MI in relation to current and discontinued use of oral contraceptives. N Engl J Med. 1981;305:420-4.
83. Rosenberg L, Kaufman DW, Helmrich SP, et al. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA. 1985;253:2965-9.
84. Rosenberg L, Miller DR, Kaufman DW, et al. Myocardial infarction in women under 50 years of age. JAMA. 1983;250:2801-6.
85. Beard CM, Griffin MR, Offord KP, et al. Risk factors for sudden cardiac death in young women in Rochester, Minnesota, 1960 through 1974. Mayo Clin Proc. 1986;61:186-91.
86. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med. 1991;325:226-30.
87. Rosenberg L, Palmer J, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med. 1990;322:213-7.
88. Inman WHW, Vessey MP, Westerholm B, et al. Thromboembolic disease and the steroidal content of oral contraceptives: a report to the Committee on Safety of Drugs. Br Med J. 1970;2:203-9.
89. Shapiro S, Slone D, Rosenberg L, et al. Oral-contraceptive use in relation to myocardial infarction. Lancet. 1979;1:743-6.
90. Fotherby K, Trayner I, Longthorne PN, et al. Metabolic investigations with Femodene - an oral contraceptive containing gestodene and ethinyloestradiol. Contraception. 1987;35:323-37.
91. Speroff L, DeCherney A, Burkman Jr RT, et al. Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins (review). Obstet Gynecol. 1993;81:1034-47.
92. Notelovitz M, Feldman EB, Gillespy M, et al. Lipid and lipoprotein changes in women taking low-dose triphasic oral contraceptives: A controlled, comparative 12-month clinical trial. Am J Obstet Gynecol. 1989;160:1269-80.
93. Salonen JT. Oral contraceptives, smoking and risk of myocardial infarction in young women. Acta Med Scand. 1982;212:141-4.
94. Miller NE, Bolton CH, Hayes TM, et al. Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: The Caerphilly and Speedwell Collaborative Heart Disease Studies. J Epidemiol Community Health. 1988;42:220-5.
95. Kivela S-L, Nissinen A, Punsar S, Puska P, Karvonen MJ. Determinants and predictors of heavy alcohol consumption among aging Finnish men. Compr Gerontol [B]. 1988;2:103-9.
96. Johnson CC, Hunter SM, Amos CI, Elder ST, Berenson GS. Cigarette smoking, alcohol and oral contraceptive use by type A adolescents - the Bogalusa Heart Study. J Behav Med. 1989;12:13-24.
97. The 1988 Joint National Committee. The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-38.
98. LaPorte R, Valvo-Gerard L, Kuller L, et al. The relationship between alcohol consumption, liver enzymes, and high density lipoprotein cholesterol. Circulation. 1981;64(III): 67-72.
99. Johnson CC, Myers L, Webber LS, Hunter SM, Srinivasan SR, Berenson GS. Alcohol consumption among adolescents and young adults: the Bogalusa Heart Study, 1981 to 1991. Am J Public Health. 1995;85(7):979-82.
100. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med. 1992;117:646-54.
101. Friedman GD, Selby JV, Quesenberry CP Jr, Armstrong MA, Klatsky AL. Precursors of essential hypertension: Body weight, alcohol and salt use, and parental history of hypertension. Prev Med. 1988;17:387-402.
102. Kris-Etherton PM, Krummel D, Russell ME, et al. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. National Cholesterol Education Program. J Am Diet Assoc. 1988;88:1373-1400.
103. Diet & Health: Implications for Reducing Chronic Disease Risk, 1989. Washington DC: National Academy of Sciences, National Research Council; National Academy Press; 1989.
104. Nicklas TA, Farris RP, Srinivasan SR, Webber LS, Berenson GS. Nutritional studies in children and implications for change: the Bogalusa Heart Study. J Adv Med. 1989;2:451-74.
105. Nicklas TA. Dietary studies of children: the Bogalusa Heart Study experience. J Am Diet Assoc. 1995;95:1127-33.
106. Nicklas TA. Dietary studies of children and young adults (1973-1988): the Bogalusa Heart Study. Am J Med Sci. 1995;310(suppl 1):S101-8.
107. Nicklas TA, Johnson CC, Myers L, Webber LS, Berenson GS. Eating patterns, nutrient intakes, and alcohol consumption patterns of young adults: the Bogalusa Heart Study. Med Exerc Nutr Health. 1995;4:316-24.
108. Jain M, Howe GR, Johnson KC, Miller AB. Evaluation of a dietary history questionnaire for epidemiologic studies. Am J Epidemiol. 1980;111(2):212-9.
109. Rasanen L. Nutrition survey of Finnish rural children. VI. Methodology study comparing the 24-hour recall and the dietary history interview. Am J Clin Nutr. 1979;32:2560-7.
110. Donahue AH. Women's health: A national plan for action. J Dent Educ. 1993;57(10):738-41.
111. Cummings NB. Women's health and nutrition research: US governmental concerns. J Am Coll Nutr. 1993; 12(4):329-36.
112. Pinn VW. The role of the NIH's Office of Research on Women's Health. Acad Med. 1994;69(9):698-702.
113. Rossouw JE, Finnegan LP, Harlan WR, Pinn VW, Clifford C, McGowan JA. The evolution of the Women's Health Initiative: Perspectives from the NIH. J Am Med Wom Assoc. 1995;50(2):50-5.